Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$414M |
| 2 |
Coca-Cola
KO
|
+$315M |
| 3 |
HCA Healthcare
HCA
|
+$263M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$824M |
| 2 |
Intel
INTC
|
+$553M |
| 3 |
Amazon
AMZN
|
+$482M |
| 4 |
Qualcomm
QCOM
|
+$403M |
| 5 |
American Electric Power
AEP
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.63% |
| 2 | Healthcare | 11.97% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Industrials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Caleres
CAL
$431M
| $1.93M | ﹤0.01% |
201,645
-16,821
| -8% | -$135K |
|
|
AIV
2652
Aimco
AIV
$387M
| $1.92M | ﹤0.01% |
427,055
-529,612
| -55% | -$2.57M |
|
2653
First Merchants
FRME
$2.68B
| $1.92M | ﹤0.01% |
82,747
+55,351
| +202% | +$1.38M |
|
2654
Alkermes
ALKS
$8.22B
| $1.91M | ﹤0.01% |
115,050
+2,185
| +2% | +$39.7K |
|
2655
Ultragenyx Pharmaceutical
RARE
$2.45B
| $1.91M | ﹤0.01% |
23,196
+3,529
| +18% | +$293K |
|
2656
VanEck Preferred Securities ex Financials ETF
PFXF
$2.41B
| $1.9M | ﹤0.01% |
99,150
+34,831
| +54% | +$664K |
|
|
AVDL
2657
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.89M | ﹤0.01% |
375,425
+31,900
| +9% | +$232K |
|
|
WW
2658
DELISTED
WW International
WW
| $1.89M | ﹤0.01% |
100,121
-18,635
| -16% | -$439K |
|
2659
Collegium Pharmaceutical
COLL
$1.15B
| $1.89M | ﹤0.01% |
90,532
+2,881
| +3% | +$52K |
|
2660
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
| $1.88M | ﹤0.01% |
73,424
-135,808
| -65% | -$3.45M |
|
2661
ICICI Bank
IBN
$108B
| $1.88M | ﹤0.01% |
190,765
-1,035,472
| -84% | -$10.3M |
|
|
SGMO
2662
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.87M | ﹤0.01% |
198,308
+167,607
| +546% | +$1.81M |
|
2663
Red Robin
RRGB
$145M
| $1.87M | ﹤0.01% |
142,294
+75,505
| +113% | +$787K |
|
2664
Nuveen Quality Municipal Income Fund
NAD
$2.74B
| $1.87M | ﹤0.01% |
128,834
-2,558
| -2% | -$37.1K |
|
|
CIM
2665
Chimera Investment
CIM
$1.04B
| $1.87M | ﹤0.01% |
75,618
+3,041
| +4% | +$81K |
|
|
REVG
2666
DELISTED
REV Group
REVG
| $1.86M | ﹤0.01% |
235,668
+181,331
| +334% | +$1.29M |
|
|
CSW
2667
CSW Industrials
CSW
$5.2B
| $1.86M | ﹤0.01% |
24,057
-8,273
| -26% | -$600K |
|
|
ZYXI
2668
DELISTED
Zynex
ZYXI
| $1.85M | ﹤0.01% |
116,740
+39,586
| +51% | +$668K |
|
2669
iShares Asia 50 ETF
AIA
$4.67B
| $1.85M | ﹤0.01% |
25,721
+12,374
| +93% | +$879K |
|
2670
Nuveen Taxable Municipal Income Fund
NBB
$447M
| $1.85M | ﹤0.01% |
82,428
+497
| +0.6% | +$11.1K |
|
2671
ADC Therapeutics
ADCT
$134M
| $1.84M | ﹤0.01% |
55,925
-8,785
| -14% | -$380K |
|
|
FSP
2672
Franklin Street Properties
FSP
$47.2M
| $1.84M | ﹤0.01% |
503,860
-83,416
| -14% | -$391K |
|
2673
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $1.84M | ﹤0.01% |
19,620
-1,223
| -6% | -$115K |
|
|
SMC
2674
Summit Midstream
SMC
$426M
| $1.83M | ﹤0.01% |
+186,967
| New | +$2.34M |
|
2675
Broadstone Net Lease
BNL
$4.11B
| $1.83M | ﹤0.01% |
+109,310
| New | +$1.81M |
|
Similar funds
Ameriprise's Q3 2020 Portfolio in Review
As of Q3 2020, Ameriprise held 3,853 positions worth $246B, up 5.3% from $233B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2020 filing shows 188 new, 1,608 increased, 1,837 reduced and 127 closed positions. Its largest new stake was NextEra Energy, Inc. 6.219% Corporate Units: 2,203,800 shares worth $105M. The largest sale was Apple, an estimated $824M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2020 buy was NextEra Energy, Inc. 6.219% Corporate Units: 2,203,800 shares worth $105M.
- Ameriprise added most to Analog Devices in Q3 2020, an estimated $414M increase.
- Ameriprise's biggest Q3 2020 reduction was Apple, cutting an estimated $824M.
- Ameriprise fully exited Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A in Q3 2020, selling an estimated $72.6M.
- Ameriprise's ten largest holdings make up 16% of its $246B portfolio in Q3 2020.
- Ameriprise opened 188 new positions and closed 127 in Q3 2020.
- Ameriprise's portfolio value rose 5.3% quarter-over-quarter to $246B.
Based on Ameriprise's 13F filing for Q3 2020, filed 16 Nov 2020.